Difference between revisions of "Team:WashU StLouis/Improve"

(Prototype team page)
 
Line 2: Line 2:
 
<html>
 
<html>
  
 +
<style>
 +
* {
 +
font-family: "Trebuchet MS"
 +
}
 +
</style>
  
<div class="column full_size judges-will-not-evaluate">
+
<p style="font-size:4vw; text-align:center">Improve</p>
<h3>★  ALERT! </h3>
+
<p style="font-size:1vw">
<p>This page is used by the judges to evaluate your team for the <a href="https://2017.igem.org/Judging/Medals">medal criterion</a> or <a href="https://2017.igem.org/Judging/Awards"> award listed above</a>. </p>
+
          We decided to improve the existing part, BBa_K1021001, which is the coding sequence for Neomycin Phosphotransferase (nptII). Neomycin phosphotransferase is an enzyme that is known to confer resistance to several antibiotics such as neomycin, kanamycin, geneticin, and paramomycin. The original creators of the part intended to use it in the selection of the fungus, C. heterosporus, and the moss, P. Patens. There didn't seem to be a codon-optimized option for DH5α E. coli which is commonly used in biological research labs. In addition, kanamycin is a common antibiotic used for selection as well.
<p> Delete this box in order to be evaluated for this medal criterion and/or award. See more information at <a href="https://2017.igem.org/Judging/Pages_for_Awards"> Instructions for Pages for awards</a>.</p>
+
</p>
 +
<p style="font-size:1vw">
 +
        In order to develop a better option for DH5α E. coli cells, we used the IDT codon optimizer to codon optimize the sequence from the original part (BBa_K1021001). After receiving the DNA, we selected a medium promoter and a medium RBS from a part (BBa_K608006) already in the registry. We ligated the two sequences together in a pSB1C3 plasmid and transformed it into DH5α E. coli cells, plating them both on a chloramphenicol plate and a kanamycin plate. Colonies appeared on both plates, confirming both the transformation and the efficacy of the gene.
 +
</p>
 +
<div style="text-align:center">
 +
    <img src="https://static.igem.org/mediawiki/2017/1/1b/T--WashU_StLouis--kanamycin1.jpg" style="width:12vw; height: 12vw">
 
</div>
 
</div>
<div class="clear"></div>
 
  
<div class="column full_size">
 
<h1>Improve</h1>
 
<p>For teams seeking to improve upon a previous part or project, you should document all of your work on this page. Please remember to include all part measurement and characterization data on the part page on the Regisrty. Please include a link to your improved part on this page.</p>
 
  
<h3>Gold Medal Criterion #2</h3>
 
<p><b>Standard Tracks:</b> Improve the function of an existing BioBrick Part. The original part must NOT be from your 2017 part number range. If you change the original part sequence, you must submit a new part. In addition, both the new and original part pages must reference each other. This working part must be different from the part documented in bronze #4 and silver #1.
 
 
<br><br>
 
<b>Special Tracks:</b> Improve the function of an existing iGEM project (that your current team did not originally create) and display your achievement on your wiki.</p>
 
 
 
</div>
 
  
  
  
 
</html>
 
</html>

Revision as of 01:35, 2 November 2017

Improve

We decided to improve the existing part, BBa_K1021001, which is the coding sequence for Neomycin Phosphotransferase (nptII). Neomycin phosphotransferase is an enzyme that is known to confer resistance to several antibiotics such as neomycin, kanamycin, geneticin, and paramomycin. The original creators of the part intended to use it in the selection of the fungus, C. heterosporus, and the moss, P. Patens. There didn't seem to be a codon-optimized option for DH5α E. coli which is commonly used in biological research labs. In addition, kanamycin is a common antibiotic used for selection as well.

In order to develop a better option for DH5α E. coli cells, we used the IDT codon optimizer to codon optimize the sequence from the original part (BBa_K1021001). After receiving the DNA, we selected a medium promoter and a medium RBS from a part (BBa_K608006) already in the registry. We ligated the two sequences together in a pSB1C3 plasmid and transformed it into DH5α E. coli cells, plating them both on a chloramphenicol plate and a kanamycin plate. Colonies appeared on both plates, confirming both the transformation and the efficacy of the gene.